- A total of 14 PUERTA participating sites, 12 US and 2 Australian, in the Phase 2A trial of ALT-100 mAb in moderate to severe ARDS
- Aqualung awarded a $3M NIH R44 grant supporting the PUERTA Phase 2A Clinical Trial
Category Archives: AZBio News
BIO5 Institute Expands its Innovative Biosciences Research Model to Phoenix
The BIO5 Institute at the University of Arizona is set to embark on a groundbreaking journey by officially expanding its footprint to Phoenix. This move marks a significant step in fostering collaborative biosciences research across Arizona and beyond. Continue reading
AHCCCS Requests Federal Authority To Expand Eligibility for KidsCare
Nearly 10,000 More Children Could Become Eligible for CoverageContinue reading
Researchers, PIs, Technologists: Contact us with your wearable solutions for a chance to join WearTech Center’s next applied research cohort with matching funding up to $250,000.
Arizona’s WearTech Applied Research Center is developing its fourth cohort of applied research projects and is seeking novel wearable solutions to address challenges and opportunities within the existing healthcare and industrial sectors.Continue reading
ASU ranks in top 5 for inventions, patents, patent deals and startups
Arizona State University ranked among the top five research institutions without a medical school for the first time in fiscal year 2022 for inventions disclosed, U.S. patents secured, patent licenses and option deals closed, and startups launched, according to the Association of University Technology Managers’ latest survey of 180 reporting institutions on licensing activities at U.S. universities and research institutions.Continue reading
Tech Hubs grant puts ASU at ground zero for medical device manufacturing
Skysong Innovations will help devices get to marketContinue reading
ABRC issues 30-Day Notice for the Opening of Request for Grant Applications for the study of Psilocybin Whole Mushrooms
The Arizona Department of Health Services (ADHS), through the Arizona Biomedical Research Centre (ABRC), will be opening a solicitation approximately thirty (30) days from the publication of this notice for the acceptance of grant applications to conduct clinical trials on the efficacy of Psilocybin Whole Mushrooms on various conditions, disorders, and diseases.
This announcement serves as the notice required pursuant to by Laws 2023, Chapter 139 (56th Leg 1st Reg), SB 1726, Sec. 6(B)1
(https://www.azleg.gov/legtext/56leg/1R/laws/0139.pdf).Continue reading
HonorHealth Research Institute is first in Arizona to offer leukemia patients a treatment that encourages natural tumor suppression
SCOTTSDALE, Ariz. — Nov. 22, 2023 — Cancer patients whose leukemia returns after initial treatments have few options and a poor prognosis, but a first-in-Arizona clinical trial opening at HonorHealth Research Institute is giving hope to those with this all-too-common blood cancer.Continue reading
Arizona Commerce Authority Announces Finalists for the Arizona Innovation Challenge
Four bio & life sciences companies advance to the final roundContinue reading